Idexx Laboratories Inc vs Johnson & Johnson
IDXX vs JNJ — side-by-side comparison from reported financials. IDXX leads 5, JNJ leads 4 of 9 comparable metrics.
Idexx Laboratories Inc
IDXX · Healthcare
$518.00+0.95%Solid
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | IDXX | JNJ |
|---|---|---|
| Price | $518.00 | $261.79 |
| Market cap | $40.8B | $631B |
| Revenue (TTM) | $4.55B | $97.9B |
| Revenue growth | +8.5% | +5.6% |
| Net margin | 25.0% | 21.5% |
| Free cash flow | $1.25B | $22.2B |
| Net cash (debt) | ($195M) | ($27.8B) |
| 1-year price return | -17.6% | +37.0% |
| P/E | 35.8 | 29.9 |
| P/E vs own history (cheap-side %) | 99% | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | 72% | 26% |
| Altman Z-score | 17.91 | — |
| CV checks passed | 10 of 10 | 10 of 10 |
| Employees | 11,000 | 140,800 |
Full résumé-style profiles: IDXX CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.